(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
5.12% ¥ 5 010.00
Live Chart Being Loaded With Signals
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment...
Stats | |
---|---|
Объем за сегодня | 9.59M |
Средний объем | 4.28M |
Рыночная капитализация | 9 606.67B |
EPS | ¥0 ( 2024-04-25 ) |
Last Dividend | ¥15.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 47.85 |
ATR14 | ¥4.28 (0.09%) |
Объем Корреляция
Daiichi Sankyo Company, Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Daiichi Sankyo Company, Корреляция - Валюта/Сырье
Daiichi Sankyo Company, Финансовые показатели
Annual | 2023 |
Выручка: | ¥1 601.69B |
Валовая прибыль: | ¥1 186.37B (74.07 %) |
EPS: | ¥104.69 |
FY | 2023 |
Выручка: | ¥1 601.69B |
Валовая прибыль: | ¥1 186.37B (74.07 %) |
EPS: | ¥104.69 |
FY | 2022 |
Выручка: | ¥1 278.48B |
Валовая прибыль: | ¥914.95B (71.57 %) |
EPS: | ¥56.96 |
FY | 2022 |
Выручка: | ¥1 044.89B |
Валовая прибыль: | ¥691.56B (66.19 %) |
EPS: | ¥34.94 |
Financial Reports:
No articles found.
Daiichi Sankyo Company, Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥15.00 (N/A) |
¥0 (N/A) |
¥15.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥4.08 | 2000-03-28 |
Last Dividend | ¥15.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥443.25 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.05 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.84 | |
Div. Directional Score | 8.62 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8058.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7315.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6564.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
5915.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4578.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3834.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3085.T | Ex Dividend Knight | 2023-06-29 | Semi-Annually | 0 | 0.00% | |
1951.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9507.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
8395.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.125 | 1.500 | 7.49 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0580 | 1.200 | 8.07 | 9.68 | [0 - 0.3] |
returnOnEquityTTM | 0.125 | 1.500 | 9.72 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.335 | -1.000 | 6.65 | -6.65 | [0 - 1] |
currentRatioTTM | 3.01 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.522 | 0.800 | 5.75 | 4.60 | [0.8 - 2.5] |
cashRatioTTM | 0.895 | 1.500 | 6.14 | 9.21 | [0.2 - 2] |
debtRatioTTM | 0.0294 | -1.500 | 9.51 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 11.63 | 1.000 | 6.80 | 6.80 | [3 - 30] |
operatingCashFlowPerShareTTM | 312.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 248.50 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0603 | -1.500 | 9.76 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.741 | 1.000 | 0.988 | 0.988 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.132 | 1.000 | 9.36 | 9.36 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 5.89 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.463 | 0.800 | -0.248 | -0.199 | [0.5 - 2] |
Total Score | 12.41 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 47.86 | 1.000 | 5.27 | 0 | [1 - 100] |
returnOnEquityTTM | 0.125 | 2.50 | 9.82 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 248.50 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.998 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 312.54 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.335 | 1.500 | 6.65 | -6.65 | [0 - 1] |
pegRatioTTM | -0.562 | 1.500 | -7.08 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.374 | 1.000 | 3.15 | 0 | [0.1 - 0.5] |
Total Score | 4.84 |
Daiichi Sankyo Company,
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihypertensive agent; levofloxacin, an antibacterial agent; pravastatin for hypercholesterolemia treatment; and loxoprofen, an anti-inflammatory analgesic. In addition, the company offers colesevelam for treating hypercholesterolemia and type 2 diabetes mellitus treatment; and ferric carboxymaltose and iron sucrose injections for treating anemia. Further, it provides Lulu, a combination cold remedy; Loxonin S, an antipyretic analgesic /anti-inflammatory analgesic; Transino for melasma improvement and treating against spots and freckles; Minon, a skincare product; and Breath Labo and Clean Dental oral care products, as well as Silodosin for dysuria; Gefitinib for malignant tumours; Bicalutamide for prostate cancer; and Tamoxifen, an anti-breast cancer agent. Additionally, the company offers adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. It also provides pharmaceuticals and drugs for animals, cosmetics, medical equipment, food products, drinking water, active pharmaceutical ingredients, and intermediates. It has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer. The company was founded in 1899 and is headquartered in Tokyo, Japan.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа